Synthesis, Molecular Docking, and Biological Evaluation of Pyridin-3-yl-Pyrimidin-2-yl-Triazole Derivatives as Anti-cancer Agents

References

• Douglas Hanahan and Robert A. Weinberg, “Hallmarks of Cancer: The Next Generation,” Cell 144, no. 5 (2011): 646–74. doi:10.1016/j.cell.2011.02.013
   PubMed Web of Science ®Google Scholar
• Harold J. Burstein, Sarah Temin, Holly Anderson, Thomas A. Buchholz, Nancy E. Davidson, Karen E. Gelmon, Sharon H. Giordano, Clifford A. Hudis, Diana Rowden, Alexander J. Solky, et al., “ Adjuvant Endocrine Therapy for Women with Hormone Receptor-positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update,” Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 32, no. 21 (2014): 2255–69. doi:10.1200/JCO.2013.54.2258
   PubMed Web of Science ®Google Scholar
• World Cancer Research Fund International. “Worldwide Data,” https://www.wcrf.org (accessed October 01, 2022).
   Google Scholar
• Renaud Capdeville, Elisabeth Buchdunger, Juerg Zimmermann, and Alex Matter, “Glivec (STI571, Imatinib), a Rationally Developed, Targeted Anticancer Drug,” Nature Reviews Drug Discovery 1, no. 7 (2002): 493–502. doi:10.1038/nrd839
   PubMed Web of Science ®Google Scholar
• Hagop Kantarjian, Charles Sawyers, Andreas Hochhaus, Francois Guilhot, Charles Schiffer, Carlo Gambacorti-Passerini, Dietger Niederwieser, Debra Resta, Renaud Capdeville, Ulrike Zoellner, et al., “Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia,” The New England Journal of Medicine 346, no. 9 (2002): 645–52. doi:10.1056/NEJMoa011573
   PubMed Web of Science ®Google Scholar
• Bhushan Nagar, William G. Bornmann, Patricia Pellicena, Thomas Schindler, Darren R. Veach, W. Todd Miller, Bayard Clarkson, and John Kuriyan, “Crystal Structures of the Kinase Domain of c-Abl in Complex with the Small Molecule Inhibitors PD173955 and Imatinib (STI-571),” Cancer Research 62, no. 15 (2002): 4236–43.
   PubMed Web of Science ®Google Scholar
• Thomas Schindler, William Bornmann, Particia Pellicena, W. Todd Miller, Bayard Clarkson, and John Kuriyan, “Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase,” Science (New York, N.Y.) 289, no. 5486 (2000): 1938–42. doi:10.1126/science.289.5486.1938
   PubMed Web of Science ®Google Scholar
• Naima Agouram, El Mestafa El Hadrami, and Abdeslem Bentama, “1,2,3-Triazoles as Biomimetics in Peptide Science,” Molecules 26, no. 10 (2021): 2937. doi:10.3390/molecules26102937
   PubMed Web of Science ®Google Scholar
• Hartmuth C. Kolb, M. G. Finn, and K. Barry Sharpless, “Click Chemistry: Diverse Chemical Function from a Few Good Reactions,” Angewandte Chemie International Edition 40, no. 11 (2001): 2004–21. doi:10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5
   PubMed Web of Science ®Google Scholar
• Vsevolod V. Rostovtsev, Luke G. Green, Valery V. Fokin, and K. Barry Sharpless, “Stepwise Huisgen Cycloaddition Process: Copper (I) catalyzed Regioselective“Ligation” of Azide and Terminal Alkynes,” Angewandte Chemie International Edition 41, no. 14 (2002): 2596–9. doi:10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4
   PubMed Web of Science ®Google Scholar
• Christian W. Tornøe, Caspar Christensen, and Morten Meldal, “Peptidotriazoles on Solid Phase: [1,2,3]-Triazole by Regiospecific Copper (I)-catalyzed 1,3-Dipolar Cycloaddition of Terminal Alkynes to Azide,” The Journal of Organic Chemistry 67, no. 9 (2002): 3057–64. doi:10.1021/jo011148j
   PubMed Web of Science ®Google Scholar
• Valentin O. Rodionov, Valery V. Fokin, and M. G. Finn, “Mechanism of the Ligation-free CuI-catalyzed Azide-alkyne Cycloaddition Reaction,” Angewandte Chemie (International ed. in English) 44, no. 15 (2005): 2210–5. doi:10.1002/anie.200461496
   PubMed Web of Science ®Google Scholar
• Xiangyi Jiang, Xia Hao, Lanlan Jing, Gaochan Wu, Dongwei Kang, Xinyong Liu, and Peng Zhan, “Recent Applications of Click Chemistry in Drug Discovery,” Expert Opinion on Drug Discovery 14, no. 8 (2019): 779–89. doi:10.1080/17460441.2019.1614910
   PubMed Web of Science ®Google Scholar
• Alisha Rani, Gurjaspreet Singh, Akshpreet Singh, Ubair Maqbool, Gurpreet Kaur, and Jandeep Singh, “CuAAC-ensembled 1,2,3-Triazole-linked Isosteres as Pharmacophores in Drug Discovery: Review,” Chemical Records 20, no. 4 (2020): 253–72.
   PubMedGoogle Scholar
• Khurshed Bozorov, Jiangyu Zhao, and Haji A. Aisa, “1,2,3-Triazole-containing Hybrids as Leads in Medicinal Chemistry: A Recent Overview,” Bioorganic & Medicinal Chemistry 27, no. 16 (2019): 3511–31. doi:10.1016/j.bmc.2019.07.005
   PubMed Web of Science ®Google Scholar
• Bhavna Saroha, Gourav Kumar, Ramesh Kumar, Meena Kumari, and Suresh Kumar, “A Minireview of 1,2,3-Triazole Hybrids with O-Heterocycles as Leads in Medicinal Chemistry,” Chemical Biology & Drug Design 100, no. 6 (2021): 843–69. doi:10.1111/cbdd.13966
   PubMed Web of Science ®Google Scholar
• Ravi Varala, Hari Babu Bollikolla, and Chandra Mohan Kurmarayuni, “Synthesis of Pharmacological Relevant 1,2,3-Triazole and Its Analogues-A Review,” Current Organic Synthesis 18, no. 2 (2021): 101–24. doi:10.2174/1570179417666200914142229
   PubMed Web of Science ®Google Scholar
• Lian-Shun Feng, Man-Jie Zheng, Feng Zhao, and Duan Liu, “1,2,3-Triazole Hybrids with Anti-HIV-1 Activity,” Archiv Der Pharmazie 354, no. 1 (2021): e2000163. doi:10.1002/ardp.202000163
   PubMed Web of Science ®Google Scholar
• Zhi Xu, “1,2,3-Triazole-containing Hybrids with Potential Antibacterial Activity against Methicillin-resistant Staphylococcus aureus (MRSA),” European Journal of Medicinal Chemistry 206 (2020): 112686. doi:10.1016/j.ejmech.2020.112686
   PubMed Web of Science ®Google Scholar
• Ting Liang, Xiangyang Sun, Wenhong Li, Guihua Hou, and Feng Gao, “1,2,3-Triazole-containing Compounds as Anti-lung Cancer Agents: Current Developments, Mechanisms of Action, and Structure-activity Relationship,” Frontiers in Pharmacology 12 (2021): 661173. doi:10.3389/fphar.2021.661173
   PubMed Web of Science ®Google Scholar
• Mohammad Mahboob Alam, “1,2,3-Triazole Hybrids as Anticancer Agents: A Review,” Archiv Der Pharmazie 355, no. 1 (2022): e2100158. doi:10.1002/ardp.202100158
   PubMed Web of Science ®Google Scholar
• Bo Zhang, “Comprehensive Review on the Anti-bacterial Activity of 1,2,3-Triazole Hybrids,” European Journal of Medicinal Chemistry 168 (2019): 357–72. doi:10.1016/j.ejmech.2019.02.055
   PubMed Web of Science ®Google Scholar
• Nisha Poonia, Aman Kumar, Vijay Kumar, Monika Yadav, and Kashmiri Lal, “Recent Progress in 1H-1,2,3-Triazoles as Potential Antifungal Agents,” Current Topics in Medicinal Chemistry 21, no. 23 (2021): 2109–33. doi:10.2174/1568026621666210913122828
   PubMed Web of Science ®Google Scholar
• Pegah Nouraie, Shahram Moradi Dehaghi, and Alireza Foroumadi, “Coumarin-1,2,3-Triazole Hybrid Derivatives: Green Synthesis and DFT Calculations,” Synthetic Communications 49, no. 3 (2019): 386–94. doi:10.1080/00397911.2018.1557686
   Web of Science ®Google Scholar
• Setareh Moghimi, Somayeh Salarinejad, Mahsa Toolabi, Loghman Firoozpour, Seyed Esmaeil Sadat Ebrahimi, Fatemeh Safari, Fatemeh Madani-Qamsari, Somayeh Mojtabavi, Mohammad Ali Faramarzi, Saeed Karima, et al, “Synthesis, In-vitro Evaluation, Molecular Docking, and Kinetic Studies of Pyridazine-triazole Hybrid System as Novel α-Glucosidase Inhibitors,” Bioorganic Chemistry 109 (2021): 104670. doi:10.1016/j.bioorg.2021.104670
   PubMed Web of Science ®Google Scholar
• Sara Akrami, Loghman Firoozpour, Fereshteh Goli-Garmroodi, Setareh Moghimi, Mohammad Mahdavi, Afsaneh Zonouzi, and Alireza Foroumadi, “One-pot Synthesis of Oxoisoindoline-1, 2, 3-Triazole Hybrid by a Ugi–Click Reaction,” Synthetic Communications 46, no. 20 (2016): 1708–12. doi:10.1080/00397911.2016.1223313
   Web of Science ®Google Scholar
• Setareh Moghimi, Fereshteh Goli-Garmroodi, Hedieh Pilali, Mohammad Mahdavi, Loghman Firoozpour, Hamid Nadri, Alireza Moradi, Ali Asadipour, Abbas Shafiee, and Alireza Foroumadi, “Synthesis and Anti-acetylcholinesterase Activity of Benzotriazinone-triazole Systems,” Journal of Chemical Sciences 128, no. 9 (2016): 1445–9. doi:10.1007/s12039-016-1154-5
   Web of Science ®Google Scholar
• Ali Asadipour, Saeedeh Noushini, Setareh Moghimi, Mohammad Mahdavi, Hamid Nadri, Alireza Moradi, Shabnam Shabani, Loghman Firoozpour, and Alireza Foroumadi, “Synthesis and Biological Evaluation of Chalcone-triazole Hybrid Derivatives as 15-LOX Inhibitors,” Zeitschrift Für Naturforschung B 73, no. 2 (2018): 77–83. doi:10.1515/znb-2017-0115
   Google Scholar
• Setareh Moghimi, Fereshteh Goli‐Garmroodi, Maryam Allahyari‐Devin, Hedieh Pilali, Malihe Hassanzadeh, Shabnam Mahernia, Mohammad Mahdavi, Loghman Firoozpour, Massoud Amanlou, and Alireza Foroumadi, “Synthesis, Evaluation, and Molecular Docking Studies of Aryl Urea‐Triazole‐Based Derivatives as Anti‐Urease Agents,” Archiv Der Pharmazie 351, no. 7 (2018): 1800005. doi:10.1002/ardp.201800005
   Web of Science ®Google Scholar
• Mehrdad Mehrazar, Mahdi Hassankalhori, Mahsa Toolabi, Fereshteh Goli, Setareh Moghimi, Hamid Nadri, Syed Nasir Abbas Bukhari, Loghman Firoozpour, and Alireza Foroumadi, “Design and Synthesis of Benzodiazepine-1, 2, 3-Triazole Hybrid Derivatives as Selective Butyrylcholinesterase Inhibitors,” Molecular Diversity 24, no. 4 (2020): 997–1013. doi:10.1007/s11030-019-10008-x
   PubMed Web of Science ®Google Scholar
• Daniel Moock, Tobias Wagener, Tianjiao Hu, Timothy Gallagher, and Frank Glorius, “Enantio- and Diastereoselective, Complete Hydrogenation of Benzofurans by Cascade Catalysis,” Angewandte Chemie (International ed. in English) 60, no. 24 (2021): 13677–81. doi:10.1002/anie.202103910
   PubMed Web of Science ®Google Scholar
• Vanesa Nozal, Alfonso García-Rubia, Eva P. Cuevas, Concepción Pérez, Carlota Tosat-Bitrián, Fernando Bartolomé, Eva Carro, David Ramírez, Valle Palomo, and Ana Martínez, “From Kinase Inhibitors to Multitarget Ligands as Powerful Drug Leads for Alzheimer’s Disease Using Protein-templated Synthesis,” Angewandte Chemie (International ed. in English) 60, no. 35 (2021): 19344–54. doi:10.1002/anie.202106295
   PubMed Web of Science ®Google Scholar
• Ji Jianxin, Jin Yi, Hu Xiaoyu, Guo Na, Du Fengtian, Zuo Chengsen, Zhang Qiang, and Li Bogang, “N-[4-Methyl-3-(4-Pyridin-3-Yl-Pyrimidin-2-Ylamino)Phenyl]Benzamide Derivatives, a Preparation Method and Use Synthesis of Imatinib Thereof,” WO2012022217A1.
   Google Scholar
• Timothy U. Connell, Christine Schieber, Ilaria Proietti Silvestri, Jonathan M. White, Spencer J. Williams, and Paul S. Donnelly, “Copper and Silver Complexes of Tris(Triazole)Amine and Tris(Benzimidazole)Amine Ligands: Evidence That Catalysis of an Azide–Alkyne Cycloaddition (“Click”) Reaction by a Silver Tris(Triazole)Amine Complex Arises from Copper Impurities,” Inorganic Chemistry 53, no. 13 (2014): 6503–11. doi:10.1021/ic5008999
   PubMed Web of Science ®Google Scholar
• Rajavel Srinivasan, Lay Pheng Tan, Hao Wu, Peng-Yu Yang, Karunakaran A. Kalesh, and Shao Q. Yao, “High-throughput Synthesis of Azide Libraries Suitable for Direct “Click” Chemistry and in Situ Screening,” Organic & Biomolecular Chemistry 7, no. 9 (2009): 1821–8. doi:10.1039/b902338k
   PubMed Web of Science ®Google Scholar
• V. Akolkar, Amol A. Nagargoje, Vagolu S. Krishna, Dharmarajan Sriram, Jaiprakash N. Sangshetti, Manoj Damale, and Bapurao B. Shingate, “New N-Phenylacetamide-incorporated 1,2,3-Triazoles: [Et3NH][OAc]-mediated Efficient Synthesis and Biological Evaluation,” RSC Advances 9, no. 38 (2019): 22080–91. doi:10.1039/c9ra03425k
   PubMed Web of Science ®Google Scholar
• Trevor Ostlund, Faez Alotaibi, Jennifer Kyeremateng, Hossam Halaweish, Abigail Kasten, Surtaj Iram, and Fathi Halaweish, “Triazole-estradiol Analogs: A Potential Cancer Therapeutic Targeting Ovarian and Colorectal Cancer,” Steroids 177 (2022): 108950. doi:10.1016/j.steroids.2021.108950
   PubMed Web of Science ®Google Scholar
• Takayoshi Suzuki, Yuki Kasuya, Yukihiro Itoh, Yosuke Ota, Peng Zhan, Kaori Asamitsu, Hidehiko Nakagawa, Takashi Okamoto, and Naoki Miyata, “Identification of Highly Selective and Potent Histone Deacetylase 3 Inhibitors Using Click Chemistry-based Combinatorial Fragment Assembly,” PLoS One 8, no. 7 (2013): e68669. doi:10.1371/journal.pone.0068669
   PubMed Web of Science ®Google Scholar
• Pramod S. Phatak, Rajubai D. Bakale, Ravibhushan S. Kulkarni, Sambhaji T. Dhumal, Prashant P. Dixit, Vagolu Siva Krishna, Dharmarajan Sriram, Vijay M. Khedkar, and Kishan P. Haval, “Design and Synthesis of New Indanol-1,2,3-Triazole Derivatives as Potent Antitubercular and Antimicrobial Agents,” Bioorganic & Medicinal Chemistry Letters 30, no. 22 (2020): 127579. doi:10.1016/j.bmcl.2020.127579
   PubMed Web of Science ®Google Scholar
• K. A. Bhensdadia, N. H. Lalavani, and S. H. Baluja, “Synthesis of New Thieno[2,3-d]Pyrimidines Containing a 1,2,3-Triazole Ring and Their Therapeutic Response in NCI-60 Cell Line Panel,” Russian Journal of Organic Chemistry 57, no. 10 (2021): 1668–77. doi:10.1134/S107042802110016X
   Web of Science ®Google Scholar
• Mariana L. de Souza, Celso de Oliveira Rezende Junior, Rafaela S. Ferreira, Rocio Marisol Espinoza Chávez, Leonardo L. G. Ferreira, Brian W. Slafer, Luma G. Magalhães, Renata Krogh, Glaucius Oliva, Fabio Cardoso Cruz, et al., “Discovery of Potent, Reversible, and Competitive Cruzain Inhibitors with Trypanocidal Activity: A Structure-based Drug Design Approach,” Journal of Chemical Information and Modeling 60, no. 2 (2020): 1028–41. doi:10.1021/acs.jcim.9b00802
   PubMed Web of Science ®Google Scholar
• Bhumit L. Gondaliya and Khushal M. Kapadiya, “Efficient Green Chemistry Approach for the Synthesis of 1,2,3-Triazoles Using Click Chemistry through Cycloaddition Reaction: Synthesis and Cytotoxic Study,” Polycyclic Aromatic Compounds 43, no. 1 (2023): 686–98. doi:10.1080/10406638.2021.2019804
   Web of Science ®Google Scholar
• Fawzia Al-Blewi, Salma Akram Shaikh, Arshi Naqvi, Faizah Aljohani, Mohamed Reda Aouad, Saleh Ihmaid, and Nadjet Rezki, “Design and Synthesis of Novel Imidazole Derivatives Possessing Triazole Pharmacophore with Potent Anticancer Activity, and in Silico ADMET with GSK-3β Molecular Docking Investigations,” International Journal of Molecular Sciences 22, no. 3 (2021): 1162. doi:10.3390/ijms22031162
   PubMed Web of Science ®Google Scholar
• Nima Sepehri, Homa Azizian, Reza Ghadimi, Fahimeh Abedinifar, Somayeh Mojtabavi, Mohammad Ali Faramarzi, Ali Akbar Moghadamnia, Ebrahim Zabihi, Gholamhossein Mohebbi, Bagher Larijani, et al, “New 4,5-Diphenylimidazole-Acetamide-1,2,3-Triazole Hybrids as Potent α-Glucosidase Inhibitors: Synthesis, In Vitro and In Silico Enzymatic and Toxicity Evaluations,” Monatshefte Für Chemie - Chemical Monthly 152, no. 6 (2021): 679–93. doi:10.1007/s00706-021-02779-7
   Google Scholar
• Ayse Tan and Zuleyha Almaz, “A Series of 1,2,3-Triazole Compounds: Synthesis, Characterization, and Investigation of the Cholinesterase Inhibitory Properties via In Vitro and In Silico Studies,” Journal of Molecular Structure 1277 (2023): 134854. doi:10.1016/j.molstruc.2022.134854
   Web of Science ®Google Scholar
• Paul J. Bow, Valentina Adami, Agostino Marasco, Gaute Grønnevik, Dean A. Rivers, Guiseppe Alvaro, and Patrick J. Riss, “A Direct Fixation of CO2 for Isotopic Labelling of Hydantoins Using Iodine–Phosphine Charge Transfer Complexes,” Chemical Communications 58, no. 54 (2022): 7546–9. doi:10.1039/d2cc01754g
   PubMed Web of Science ®Google Scholar
• Malla Reddy Gannarapu, Sathish Babu Vasamsetti, Nagender Punna, Srigiridhar Kotamraju, and Narsaiah Banda, “Synthesis of Novel 1-Substituted Triazole Linked 1,2-Benzothiazine 1,1-Dioxido Propenone Derivatives as Potent Anti-inflammatory Agents and Inhibitors of Monocyte-to-Macrophage Differentiation,” MedChemComm 6, no. 8 (2015): 1494–500. doi:10.1039/C5MD00171D
   Web of Science ®Google Scholar
• Mahsa Toolabi, Fatemeh Safari, Adileh Ayati, Parnian Fathi, Setareh Moghimi, Somayeh Salarinejad, Roham Foroumadi, Shima H. M. E. Ketabforoosh, and Alireza Foroumadi, “Synthesis of Novel 2-Acetamide-5-Phenylthio-1,3,4-Thiadiazole-containing Phenyl Urea Derivatives as Potential VEGFR-2 Inhibitors,” Archiv Der Pharmazie 355, no. 3 (2022): 2100397. doi:10.1002/ardp.202100397
   Web of Science ®Google Scholar
• Chunfeng Li, Yimin Wang, Hongfeng Zhang, Man Li, Ziyu Zhu, and Yingwei Xue, “An Investigation on the Cytotoxicity and Caspase-mediated Apoptotic Effect of Biologically Synthesized Gold Nanoparticles Using Cardiospermum Halicacabum on AGS Gastric Carcinoma Cells,” International Journal of Nanomedicine 14 (2019): 951–62. doi:10.2147/IJN.S193064
   PubMed Web of Science ®Google Scholar
• M. Abdulla Al-Mamun, Jamiatul Husna, Masuda Khatun, Rubait Hasan, M. Kamruzzaman, K. M. F. Hoque, M. Abu Reza, and Z. Ferdousi, “Assessment of Antioxidant, Anticancer and Antimicrobial Activity of Two Vegetable Species of Amaranthus in Bangladesh,” BMC Complementary and Alternative Medicine 16, no. 1 (2016): 1–11. doi:10.1186/s12906-016-1130-0
   PubMedGoogle Scholar
• Sankar Pajaniradje, Kumaravel Mohankumar, Ramya Pamidimukkala, Srividya Subramanian, and Rukkumani Rajagopalan, “Antiproliferative and Apoptotic Effects of Sesbania Grandiflora Leaves in Human Cancer Cells,” BioMed Research International 2014 (2014): 474953. doi:10.1155/2014/474953
   PubMed Web of Science ®Google Scholar
• Zahra Rahmani and Fatemeh Safari, “Evaluating the In Vitro Therapeutic Effects of Human Amniotic Mesenchymal Stromal Cells on MiaPaca2 Pancreatic Cancer Cells Using 2D and 3D Cell Culture Model,” Tissue & Cell 68 (2021): 101479. doi:10.1016/j.tice.2020.101479
   PubMed Web of Science ®Google Scholar
• Li-Dong Wang, Qi Zhou, Jun-Ping Wei, Wan-Cai Yang, Xin Zhao, Li-Xia Wang, Jian-Xiang Zou, Shan-Shan Gao, Yong-Xin Li, and C. S. Yang, “Apoptosis and Its Relationship with Cell Proliferation, p53, Waf1p21, Bcl-2 and Cmyc in Esophageal Carcinogenesis Studied with a High Risk Population in Northern China,” World Journal of Gastroenterology 4, no. 4 (1998): 287–93. doi:10.3748/wjg.v4.i4.287
   PubMed Web of Science ®Google Scholar
• Christopher O. Bellamy, Roger D. Malcomson, David J. Harrison, and Andrew H. Wyllie, “Cell Death in Health and Disease: The Biology and Regulation of Apoptosis,” Seminars in Cancer Biology 6, no. 1 (1995): 3–16. doi:10.1006/scbi.1995.0002
   PubMed Web of Science ®Google Scholar
• Christine J. Hawkins and David L. Vaux, “Analysis of the Role of Bcl-2 in Apoptosis,” Immunological Reviews 142, no. 1 (1994): 127–39. doi:10.1111/j.1600-065x.1994.tb00886.x
   PubMedGoogle Scholar
• Xiao-Min Wang, Xiaofu Wang, Jing Li, and B. Mark Evers, “Effects of 5-Azacytidine and Butyrate on Differentiation and Apoptosis of Hepatic Cancer Cell Lines,” Annals of Surgery 227, no. 6 (1998): 922–31. doi:10.1097/00000658-199806000-00016
   PubMed Web of Science ®Google Scholar
• Ramsey Foty, “A Simple Hanging Drop Cell Culture Protocol for Generation of 3D Spheroids,” Journal of Visualized Experiments 51, no. 51 (2011): 2720. doi:10.3791/2720-v
   Google Scholar